We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

87 hedge funds and large institutions have $650M invested in GW Pharmaceuticals Plc American Depositary Shares in 2014 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 21 increasing their positions, 26 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 87 → 87 (0)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

19% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 26

25% less call options, than puts

Call options by funds: $35.4M | Put options by funds: $47M

26% less capital invested

Capital invested by funds: $884M → $650M (-$234M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
87
Holders Change
–
Holders Change %
0%
% of All Funds
2.52%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
26
Increased
21
Reduced
26
Closed
26
Calls
$35.4M
Puts
$47M
Net Calls
-$11.6M
Net Calls Change
-$6.17M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$19.6M
2
CCP
Clough Capital Partners
Massachusetts
+$17M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$16.5M
4
Capital Research Global Investors
Capital Research Global Investors
California
+$16.4M
5
CCM
Cupps Capital Management
Illinois
+$8.87M

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$21.4M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$20.6M
3
Franklin Resources
Franklin Resources
California
-$18.9M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$15.6M
5
FCM
Farallon Capital Management
California
-$9.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
26
A.R.T. Advisors
New York
$2.44M +$2.67M +30,207 New
Citadel Advisors
27
Citadel Advisors
Florida
$2.1M -$5.28M -59,676 -70%
NFA
28
Nationwide Fund Advisors
Ohio
$2.05M -$142K -1,600 -6%
EAM
29
Eventide Asset Management
Massachusetts
$2.02M – – –
MOACM
30
Mutual of America Capital Management
New York
$1.69M – – –
Millennium Management
31
Millennium Management
New York
$1.23M -$2.89M -32,650 -68%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.2M +$1.05M +11,899 +410%
Group One Trading
33
Group One Trading
Illinois
$1.17M -$151K -1,702 -11%
GLAM
34
Gardner Lewis Asset Management
Pennsylvania
$1.11M +$1.21M +13,700 New
MCM
35
Moore Capital Management
New York
$1.09M -$2.79M -31,500 -70%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$849K +$370K +4,176 +66%
Bank of New York Mellon
37
Bank of New York Mellon
New York
$777K +$850K +9,610 New
Commonwealth Equity Services
38
Commonwealth Equity Services
Massachusetts
$699K +$17K +192 +2%
EI
39
EAM Investors
California
$490K -$83.5K -944 -13%
CS
40
Credit Suisse
Switzerland
$459K +$178K +2,015 +55%
PFS
41
Prospera Financial Services
Texas
$451K +$494K +5,580 New
U
42
UBS
Switzerland
$386K -$2.6M -29,438 -86%
Credit Agricole
43
Credit Agricole
France
$323K +$354K +4,000 New
LPL Financial
44
LPL Financial
California
$313K -$799K -9,026 -69%
AAM
45
Advisors Asset Management
Colorado
$297K +$325K +3,678 New
HighTower Advisors
46
HighTower Advisors
Illinois
$288K +$316K +3,568 New
UR
47
USCA RIA
Texas
$283K +$88.5K +1,000 +40%
PP
48
Paloma Partners
Connecticut
$281K +$308K +3,480 New
FMT
49
First Mercantile Trust
Tennessee
$255K +$279K +3,150 New
VKH
50
Virtu KCG Holdings
New York
$244K -$922K -10,425 -78%
1
2
3 4 5

GWPH Hedge Fund Activity: Q3 2014 in Review

87 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q3 2014, worth a combined $650M — down 26% from $884M a quarter earlier.

Fund positioning in GWPH was balanced in Q3 2014: 26 funds opened new positions, 26 closed out, 21 added to existing stakes and 26 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $19.6M. The largest seller was Jennison Associates, exiting entirely with an estimated $21.4M sold.

  • 87 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q3 2014, unchanged from Q2 2014.
  • Funds reported $650M of GW Pharmaceuticals Plc American Depositary Shares stock for Q3 2014, down 26% quarter-over-quarter.
  • 26 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q3 2014 and 26 closed out, a net change of 0 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q3 2014 was OrbiMed, an estimated $19.6M added.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q3 2014 was Jennison Associates, an estimated $21.4M sold.

Based on aggregated 13F filings for Q3 2014.